1ère Réunion de travail de #PITOR ! Tres belle initiative de Alexandre Loupy où Centre Hépato-Biliaire, Hôpital Paul Brousse Université Paris-Saclay participera activement. Maintenant l'interopérabilité des esprits ne se fera que si les datas le sont aussi ! AP-HP Hôpital Foch Inserm Ministère Enseignement supérieur et Recherche Nicolas Revel

🔬 Vaincre la Mucoviscidose renouvelle son Appel à projets annuel pour soutenir la recherche sur la mucoviscidose (AP2024) ! 🌟 Chercheurs, soumettez vos idées innovantes pour améliorer la vie des patients. 💪 Plus d'info ici 👉 bit.ly/492tOE6?utm_so… #AP2024 Filiere Muco-CFTR

Bravo et Merci ! On ne fait pas de la politique avec un des traitements de santé publique : L'Aide Médicale d'Etat ! Suppression de l'#AME : cela aurait "un effet délétère sur notre système de santé", dénonce Nicolas Revel AP-HP via France Inter radiofrance.fr/franceinter/po…

Fortunately, we will have the 🗼Paris meeting in 2024. Hot topics will be there: lungtransplantation.org/programme

Registration is open for the 2nd Multidisciplinary Symposium on Pulmonary AMR. #AMR #Transplant #Lung Hurry to secure your spot! Learn more at 📷bit.ly/3QwVrOn Endorsed by The ISHLT ESOTtransplant MedUni Wien #ESOT_ECTTA

🚀 Excited to announce the kick-off of the NanoLung project with funding from ANR! Proud to partner with Hôpital Foch, Hôpital Bichat - Claude-Bernard AP-HP and Hôpital Marie-Lannelongue, GHPSJ #NanoLung #Research #PrecisionDiagnostics PARCC-INSERM Université Paris Cité Alexandre Loupy AntoineRoux

Nous sommes ravis de vous annoncer cette formidable collaboration avec Paris Transplant Group pour le tout nouveau projet NanoLung, dirigé par Alexandre Loupy et AntoineRoux ! ANR Hôpital Bichat - Claude-Bernard AP-HP Hôpital Marie-Lannelongue, GHPSJ PARCC-INSERM Université Paris Cité #NanoLung #Recherche

One month to go until the 2nd Multidisciplinary Symposium on AMR after lung transplantation. Endorsed by The ISHLT ESOTtransplant MedUni Wien Register now at 🔗 bit.ly/3QwVrOn

This multicentre study, headed by the University of Padova (Italy), showed that phosphorylated S6 ribosomal protein could be a useful marker in the pathological diagnosis of antibody-mediated rejection (AMR). Francesca Lunardi, Fiorella Calabrese 🔗 jhltonline.org/article/S1053-…

La mucoviscidose à la une du Le Parisien !

Had the great pleasure to present in the same session as Marc Raynaud 🇫🇷 yesterday, with an unprecedented cohort of >2000 lung transplant recipients, he is identifying distinct lung trajectories that will improve risk stratification of patients. 🌟 AmericanTransplantCongress Paris Transplant Group

What’s happening ?! Is Paris Transplant Group taking over the AMR session AmericanTransplantCongress ? Looks like it with four presentations given by Marta Sablik Gillian Divard and Michelle Elias. Paris Transplant Group #ATC2024Philly

Telomeres and anti-aging redux A small molecule activator of TERT (telomerase reverse transcriptase) reverse hallmarks of aging in mouse model and in human cell lines, without evidence of cancer risk cell.com/cell/abstract/… Cell Dr. Ron DePinho MD Anderson Cancer Center

Very happy to participate to the 4th CMV consensus meeting ⁦TTS⁩ in Montreal with all experts and friends ⁦hannah kaminski⁩ ⁦⁦Atul Humar⁩ ⁦⁦Camille Nelson Kotton⁩ ⁦Hirsch Hans⁩ ⁦Martina Sester⁩ ⁦⁦@HORUS_EU⁩ ⁦CHU de Toulouse⁩

It was a special pleasure to join many international colleagues at 4th Consensus Guidelines on Clinical Management of #CMV in SOT recipients. TTS hannah kaminski Martina Sester QIMR Berghofer Medical Research Institute

A prospective observational study including 2,882 kidney allograft recipients from 14 transplantation centers in Europe and the US show that cell-free DNA can be used to detect #kidney #allograft rejection Alexandre Loupy @olivieraubert Paris Transplant Group nature.com/articles/s4159…

🫁#transplant congress in 🗼🇫🇷 september 12&13th 2024. Meet the world experts in a wonderful city. A fantastic two day program thanks to AntoineRoux and Tereza lungtransplantation.org

EU~TRAIN large prospective multicentic 🇪🇺 trial 🧐 23 blood biomarkers -> None show association and added value to SOC for detecting rejection🚫AKR1C3 🚫CD3E🚫CD4🚫CD40🚫CD8A🚫CD9🚫CTLA4🚫FOXP3🚫GZMB🚫ID3🚫IL7R🚫MS4A1🚫MZB1, 🚫POU2F1🚫TCL1A🚫TKR4🚫TRIB1🚫AT1R🚫ETAR🚫c3AR🚫C5aR

Very interesting results about the use of ECP in combination to triple IS for reducing acute rejection, infections and CLAD. 📢 What do you think about? #lungtransplantation #immunosuppression #CLAD #lungtx #MedTwitter #ClinicalTrials

Small #ESOT_ECTTA representation in “16th international congress on lung transplantation”. Thank you so much AntoineRoux Lindstedt´s lab Tereza #DrSage Hôpital Foch for the great meeting. See you on 2026 ESOTtransplant #ESOT_ambassador